Farid, N A <br/><br/>
Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  May 2007 
 - 735-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1038/sj.clpt.6100139  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Area Under Curve<br/>Clopidogrel<br/>Cross-Over Studies<br/>Cytochrome P-450 CYP3A Inhibitors<br/>Double-Blind Method<br/>Drug Interactions<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Ketoconazole--pharmacology<br/>Male<br/>Middle Aged<br/>Piperazines--administration & dosage<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prasugrel Hydrochloride<br/>Thiophenes--administration & dosage<br/>Ticlopidine--administration & dosage